Loqtorzi
Analogs of Loqtorzi
Find cheaper analogs and generic equivalents for Loqtorzi.
ਸਰਗਰਮ ਤੱਤ: toripalimab
ਉਤਪਾਦ ਝਲਕ
About Loqtorzi
Loqtorzi is a medicine that can only be obtained with a prescription.
What it is used for
Loqtorzi is used for treating cancer under the supervision of a doctor experienced in treating cancer.
How it is used
Loqtorzi is given once every 3 weeks as an infusion (drip) into a vein. The infusion lasts 60 minutes for the first dose and, providing the medicine is well tolerated, 30 minutes for subsequent doses. Treatment should continue for up to 24 months.
How it works
The active substance in Loqtorzi, toripalimab, is a monoclonal antibody, a type of protein that has been designed to attach to a receptor called PD-1 found on cells of the immune system called T cells. Cancer cells can produce proteins (PD-L1 and PD-L2) that attach to this receptor and switch off the activity of the T cells, preventing them from attacking the cancer. By attaching to the receptor, toripalimab prevents PD-L1 and PD-L2 from switching off the T cells, thereby increasing the ability of the immune system to kill cancer cells.
Active substance: toripalimab
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.